Specialty medicines and biosimilars · Latin America
Invictus Medicines is the exclusive market-access partner for selected manufacturers entering Latin American public and private health systems. One local counterparty for registration, public tenders and collection, across the region.
Why now
Who we are
Founder
Led the largest acquisition project in UNOPS history: a USD 6.1 billion medicines programme that delivered 878 million units across 7 countries. Winner of the 2022 United Nations Procurement Award.
Harvard Kennedy School. Former Director of International Relations, Office of the President of Ecuador.
Supported by specialists in:
Where we work. Latin America, with priority markets in Colombia, Ecuador, Guatemala, Honduras and Panama, and expanding across the region. In every market we open both doors: public tenders, where volumes are firm and contracts run for months, and the private market, which opens once a product is registered.
We know how public buyers evaluate, award and pay, because we were the buyer.
What we do
Any manufacturer can find a distributor. What is hard to find is a partner who has seen every step from the buyer's side: how a product gets registered, how a bid is evaluated and how a contract gets paid. We remove the unknowns.
01
Territory-exclusive agreements by molecule or portfolio. One partner per molecule, so we never compete against you.
02
We run the sanitary registration as local applicant, from dossier to approval, then pharmacovigilance and renewals so the product stays on the market. You remain the product owner.
03
Award prices, purchase volumes and competitor registrations, tracked product by product, with a market study for your molecules on request. You do not bid blind.
04
Supplier registration, bid preparation and submission, and contract management through to collection.
05
Technical and transparent engagement with health authorities, payers, hospitals and medical societies.
06
Once a product is registered, we open the private channel: pharmacy chains, clinics and insurers.
One tender opens the door. Registration keeps it open: the same product then enters the private market.
Built for scrutiny
Contact
Tell us which products you are considering for Latin America. We take on a limited number of partners, one per molecule. We work across the region, with priority markets in Colombia, Ecuador, Guatemala, Honduras and Panama.